What’s Behind This Million Bet on Baidu Amid a 36% Rally
As Baidu surges, a hedge fund’s multi-million bet raises questions about AI, China’s digital economy, and portfolio c...
Which Dividend Etfs Are Top Tax Efficient In 2024
2024 highlights the most tax-efficient Dividend Etfs and the factors behind their efficiency, helping you pick better tax-smart options.
24,637 articles
Opinion: This Time It’s Different for the U.S. Loans Market
As Congress debates a sweeping housing bill, lenders and manufacturers warn about misaligned incentives. This opinion...
Portugal and Austria Win Council Seats; U.n. Security Council Includes
Portugal and Austria won two Western seats on the U.N. Security Council, edging out Germany after a tight vote. The m...
Markets Feel Relief as U.S. and Iran Signal Ceasefire Progress
Global markets rose late Sunday as the U.S. and Iran signaled a pause in hostilities and agreed to talks, easing fear...
Zcash Outpaces Bitcoin Gains: $25M Fundraise Drives Momentum
A major fundraise for the Zcash Open Development Lab is fueling rapid progress for privacy technology. This piece exp...
Yikes! Federal Reserve's Inflation and Social Security's 2027 COLA
The Fed's May inflation forecast could reshuffle the deck for Social Security's 2027 COLA. This guide breaks down wha...
Most Underappreciated Engine Inside Berkshire Hathaway
Berkshire Hathaway sits on a vast cash cushion, yet the hidden engine that fuels decades of growth runs deeper. This ...
Is Solana Poised for a Massive Breakout Rally Ahead
Solana has faced headwinds, but solid metrics and developing catalysts could hint at a potential rally. This guide an...
Crypto Traders Turn Hyperliquid: Oil Bets Amid Volatility
As geopolitical shocks push oil prices around, crypto traders turn hyperliquid venues to pursue oil-based bets. Learn...
Palantir: Risky Investment Hidden — Is It a Real Gem?
Palantir sits at the intersection of data software, government work, and commercial growth. Is it a palantir: risky i...
Kyverna Therapeutics vs Vertex Pharmaceuticals: 2026 Buy Guide
In 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
Soulja Boy’s $4.2 Million Judgment Keeps Growing Each Day
A civil judgment against a high-profile entertainer is piling up daily, turning an initial $4.2 million award into a ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status